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Summary 
The Dbl protein is a product of a proto-oncogene that functions as a guanine nucleotide 
exchange factor for Rho-family GTPases. It is responsible for activating the GTPases by 
facilitating the dissociation of GDP thus allowing for the binding of GTP. Intracellular 
levels of Dbl are regulated by ubiquitin-mediated proteolysis. CHIP is the E3 protein-
ubiquitin ligase responsible for this ubiquitination. More specifically, the Ubox domain 
of CHIP is critical to this interaction. Oncogenic Dbl, which lacks its spectrin domain, 
cannot bind CHIP and therefore escapes degradation. This causes accumulation of the 
oncogene product in the cell, and leads to persistent activation of its downstream 
pathways.  
 
 
 
 
 
 
 
 
 
 
  1Introduction 
Dbl was first identified by isolating fibroblast-transforming DNA from a human 
diffuse B-cell lymphoma
(7). Since its discovery, >70 other proteins have been categorized 
as members of the Dbl family
(3, 6, 19, 22). Most of these proteins have been found to act as 
guanine nucleotide exchange factors (GEFs) that modulate the activity of Rho-like 
GTPases
(3, 20). These G-proteins are turned on by the exchange of GDP for GTP with the 
help of a GEF which catalyzes the dissociation of GDP. Once activated, GTPases 
stimulate a cascade of events affecting cytoskeletal structure and gene transcription 
among other cellular functions
(11, 18). Members of the Dbl family are identified as such by 
the presence of a Dbl-homology (DH) domain adjacent to a plekstrin homology (PH) 
domain
(9, 10). The DH domain is responsible for the GEF-activity, while the PH domain 
contributes to the intracellular localization of the protein
(22). Five-prime recombinations 
result in the loss of the amino-terminal half of proto-Dbl, producing a variant with 
elevated oncogenic potential, known as onco-Dbl
(9). This increased oncogenic potential is 
associated with increased GEF activity in vivo
(9). The molecular mechanisms that 
underlie the increased oncogenic potential exhibited by onco-Dbl are poorly understood.  
One model for Dbl regulation is based on findings that proto-Dbl is a short-lived 
protein that is regulated by the ubiquitin-mediated proteolysis. Furthermore, onco-Dbl 
escapes this mode of negative regulation
(8, 12, 21). Recently, it was found that proto-Dbl is 
heavily ubiquitinated and accumulates upon proteasomal inhibition in vivo, and that this 
regulatory mechanism is attenuated in the case of onco-Dbl
(12). In addition, proto-Dbl was 
shown to interact with Hsc70
(14) and Hsp90
(12), molecular chaperones that aid in refolding 
misfolded proteins
(4). It is thought that these chaperones are involved in intracellular 
  2‘triage decision’, determining whether a protein will be refolded or sent to the proteasome 
for degradation
(4). Bi et al. proposed that an intramolecular interaction between the amino 
terminus of proto-Dbl and the PH domain maintains the protein’s basal, inhibited state in 
which the catalytic DH domain is not accessible to the substrate GTPase. Our objective 
was to determine whether other cellular factors are involved in regulating proto-Dbl’s 
activity, and to better understand the modes that regulate Dbl action.  
The binding of proto-Dbl to both Hsc70 and Hsp90 suggests that these molecular 
chaperones play a role in regulating the stability of proto-Dbl
(12, 14). Furthermore, a 
protein known as CHIP (carboxyl terminus of Hsc70-interacting protein) has been shown 
to interact with Hsc70 and therefore may also be important for the regulation of proto-
Dbl
(4). CHIP is a 35 kDa E3 ubiquitin-protein ligase that is responsible for attaching poly-
ubiquitin chains to its substrates, thereby targeting them for proteasomal degradation
(5). 
CHIP contains three tandem TPR (tetratricopeptide repeat) domains at the amino 
terminus that mediate binding to Hsc70
(1) and a Ubox domain encoding ubiquitin ligase 
activity
(16). Here, we set to test the hypothesis that CHIP is the ligase that regulates proto-
Dbl levels through ubiquitin-mediated proteolysis
(12).  
Furthermore, we used truncation mutants of CHIP to elucidate the importance of 
specific domains of CHIP in regulating proto-Dbl expression levels. 
 
 
 
 
 
  3Materials and Methods 
Molecular Constructs. The proto-Dbl (residues 1-925), onco-Dbl (residues 498-925) 
were previously described 
(14). S-tagged proto- and onco-Dbl were generated by PCR 
using primers containing in-frame amino terminal S-tag (Novagen), and ligated into the 
pCMV6 vector. PCEFL-GST-proto-Dbl and onco-Dbl were generated by ligation of the 
corresponding cDNAs into the pCEFL-GST vector, in frame with a 5’ GST tag (generous 
gift of Yi Zheng, Cincinnati Children's Hospital Medical Center, and Silvio Gutkind, 
National Institute of Dental and Craniofacial Research). CHIP cDNAs (a generous gift 
from Cam Patterson, University of North Carolina) were ligated into pcDNA4.1 HisMax 
vector (Invitrogen) to generate Xpress-tagged CHIP constructs. CHIP(ΔUbox) contains a 
stop codon at residue 230. All constructs were verified by restriction mapping and 
sequencing at the Cornell BioResource facility. To disrupt the expression of endogenous 
CHIP we ligated short DNA oligomer containing BglII-HindIII overhangs, 19 bp of sense 
mouse CHIP cDNA starting at position 1242, a connecting loop, and the same CHIP 
sequence in the antisense orientation, into the pSUPER vector (generous gift of Olivier 
Staub, University of Lausanne, Switzerland) which was then used for siRNA 
experiments. 
 
Antibodies. Anti-Myc (9E10) and anti-GST antibodies were from Covance Inc. Anti-Dbl 
antibodies (sc-89 and sc-28582) were purchased from Santa Cruz Biochemicals. Anti-
Hsc70 (SPA-815 and SPA-820) were from StressGen Biotechnologies. S-protein-HRP 
conjugates and S-protein cross-linked sepharose were from Novagen. Anti-Xpress tag 
  4antibody was from Invitrogen. Alexa488-conjugated secondary antibodies were from 
Molecular Probes. 
 
Cell Culture. Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM). 
NIH3T3 cells were cultured with 10% bovine calf serum while COS7 cells were cultured 
with 10% fetal bovine serum. Cells were transfected with plasmid DNA using either 
FuGENE6 (Roche) or LipofectAmine2000 (Inivitrogen).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  5Results 
Proto-Dbl but not onco-Dbl interacts with CHIP. It was recently found that proto-Dbl is 
degraded by ubiquitin-mediated proteolysis
(12). Since steady-state expression levels of 
onco-Dbl are about 100-fold those of proto-Dbl, onco-Dbl appears to escape the mode of 
regulation that proto-Dbl is subject to
(12). Further support of this model is the observation 
that the half-life of proto-Dbl is significantly shorter than onco-Dbl
(21). As a ubiquitin-
protein ligase, CHIP may play a role in this process
(5). To explore CHIP’s possible role in 
Dbl regulation, we transiently co-transfected COS7 cells with a plasmid encoding GST-
tagged proto-Dbl, GST-tagged onco-Dbl or GST alone together with Myc-tagged CHIP. 
The cells were lysed forty-eight hours later and association between the GST proteins and 
CHIP were visualized by SDS-PAGE and western blotting (Figure 1).  We found that 
CHIP interacts with proto-Dbl but not with onco-Dbl. This observation suggests that 
CHIP may be the ligase that attaches poly-ubiquitin chains to Dbl, thus ‘addressing’ it for 
degradation. Furthermore, since the spectrin domain is the only recognizable motif of 
proto-Dbl that is missing from onco-Dbl, this domain may mediate the interaction 
between proto-Dbl and CHIP.  
 
Proto-Dbl but not onco-Dbl is ubiquitinated when CHIP is present. Data courtesy of 
Dr. Elena Kamynina
(12). The relative stability of onco-Dbl as compared to proto-Dbl 
suggests that proto-Dbl may be degraded at a faster rate. In order to determine if this 
difference is due to differential ubiquitination, COS7 cells were transiently co-transfected 
with either GST-tagged proto-Dbl or GST-tagged onco-Dbl together with Myc-tagged 
ubiquitin. The cells were treated with the proteasomal inhibitor MG132 and were lysed 
  6forty-eight hours after transfection. Cell lysates were incubated with glutathione 
sepharose beads and levels of ubiquitin and GST proteins were visualized by SDS-PAGE 
and Western blotting (Figure 2). We found that proto-Dbl, but not onco-Dbl, is heavily 
ubiquitinated in vivo. This suggests that proto-Dbl levels are regulated by ubiquitination 
and that CHIP may be the ubiquitin ligase that associates with proto-Dbl. Furthermore, 
this observation suggests that the spectrin domain, which is missing from onco-Dbl, may 
be responsible for Dbl’s association with CHIP.  
 
CHIP regulates the steady-state levels of proto-Dbl. The selective interaction between 
proto-Dbl (but not onco-Dbl) and CHIP suggests that CHIP may be the ligase responsible 
for attaching a poly-ubiquitin chain to proto-Dbl, thus targeting it for degradation. In 
order to test this hypothesis, we transfected NIH3T3 cells with small interfering RNA 
(siRNA) specific for endogenous CHIP. As shown in Figure 3, transfection with the 
CHIP siRNA (but not with control siRNA) decreases the levels of endogenous CHIP in 
the cells by 51%. Furthermore, we observed that concomitant with the reduction in CHIP 
protein levels, the levels of proto-Dbl increased by 58%. At the same time, actin levels in 
the cell were not changed, suggesting that the effect of CHIP on Dbl levels is specific. 
The inverse relationship between the steady-state levels of CHIP and those of Dbl 
suggests that CHIP is involved in the degradation of proto-Dbl. It is likely that CHIP is 
the ligase that ubiquitinates proto-Dbl, probably by catalyzing its ubiquitination and 
proteasomal degradation. 
 
  7CHIP regulates steady-levels of proto-Dbl but not onco-Dbl in a dose-dependent 
manner. The results from the siRNA experiment suggest that CHIP is a ubiquitin ligase 
that regulates proto-Dbl levels. Since onco-Dbl does not associate with CHIP (Figure 1), 
we hypothesized that the over-expression of CHIP would not change the expression 
levels of onco-Dbl. In order to specifically address this hypothesis, we asked whether the 
expression levels of onco-Dbl or proto-Dbl are altered by overexpression of CHIP. We 
co-transfected COS7 cells with s-tagged proto-Dbl or s-tagged onco-Dbl, together with 
increasing amounts of Xpress-tagged CHIP cDNA. The cells were lysed forty-eight hours 
after the transfection and protein levels were visualized by SDS-PAGE and Western 
blotting (Figure 4). We observed that as the expression levels of CHIP increased, 
expression levels of proto-Dbl decreased. In contrast, the expression levels of onco-Dbl 
were not affected by over-expression of CHIP. These observations indicate that CHIP is 
the ubiquitin ligase that regulates proto-Dbl levels and that onco-Dbl escapes this 
regulation.  
 
Interaction between CHIP and proto-Dbl is mediated by CHIP’s Ubox domain. We 
then explored the domain(s) of CHIP that are important for regulation of proto-Dbl 
levels. Toward this end, we utilized truncation mutants that lack either the ubiquitin 
ligase domain (the ΔUbox construct in which a stop codon was inserted at residue 
230
(12)), or the chaperone interaction domain (the ΔTPR construct, which had residues 
32-145 deleted
(4))
(15). We found that proto-Dbl levels were not significantly affected by 
expression of the CHIP(ΔUbox) reagent, indicating that the ubiquitin ligase domain is 
critical for regulating Dbl levels. 
  8CHIP(ΔTPR) mutant has a dominant negative effect on the regulation of proto-Dbl. 
Interestingly, we found that upon expression of the CHIP(ΔTPR) construct, proto-Dbl 
levels increased in a dose-responsive manner (Figure 4A). Such dominant-negative 
behavior could be explained based on known existence of CHIP homo-dimers
(17). We 
hypothesize that each molecule in the dimer must bind to Hsc70 for its activity. Thus 
CHIP(ΔTPR), which cannot bind Hsc70, may dimerize with the endogenous CHIP, 
thereby sequestering it and inhibiting its ligase activity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  9Discussion 
  The molecular mechanisms by which of the regulation of the guanine nucleotide 
exchange factor Dbl is regulated are incompletely understood. Here, we propose a novel 
regulatory mechanism involving the regulation of proto-Dbl steady-state levels through 
ubiquitin-mediated proteasomal degradation. We identified CHIP as a ligase that 
facilitates ubiquitination of proto-Dbl, thus targeting it for proteasomal degradation. 
Importantly, we show that onco-Dbl escapes this mode of regulation, probably due to 
lacking the spectrin domain that mediates binding between the GEF and the molecular 
chaperones Hsc70 and Hsp90. 
It has been shown that some members of the Dbl family, such as Dbl and Vav, 
display increased transforming potential when their amino terminus is deleted
(2, 13). This 
enhanced oncogenic potential was initially attributed to an auto-inhibitory function of 
Dbl’s amino terminus. Bi et al. suggested that through an intramolecular mechanism, 
Dbl’s amino terminus binds to its PH domain thereby limiting access of the GTPase to 
the catalytic DH domain of the GEF
(2). Recent evidence suggests that this mechanism is 
more complex and involves several other factors. We observed that proto-Dbl, but not 
onco-Dbl, is heavily ubiquitinated suggesting that a ubiquitin ligase may play a role in 
the regulation of Dbl
(12). Here, we identified this ubiquitin ligase as CHIP. We show that 
CHIP associates with proto-Dbl, but not onco-Dbl. Additionally, we observed that as 
CHIP levels increase, proto-Dbl levels decrease. Conversely, as endogenous CHIP levels 
decrease, the levels of proto-Dbl increase. Furthermore, we explored which domain(s) of 
CHIP is/are important for its function. Previous data provides as evidence that the Ubox 
domain is responsible for ligation of ubiquitin to the substrate protein 
(16). Our data 
  10supports this conclusion, as we found that the steady-state levels of proto-Dbl levels did 
not change when the ligase-defective mutant CHIP(ΔUbox) was over-expressed. We also 
found that proto-Dbl levels increased upon over-expression of CHIP(ΔTPR), raising the 
possibility that this mutant somehow inhibits the activity of endogenous CHIP. This 
study describes a novel mechanism that regulates an oncogenic GEF and offers the 
possibility that other oncogenic proteins are similarly regulated.  
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  14Figure Legends 
Figure 1. Proto-Dbl but not onco-Dbl interacts with CHIP. Proto-Dbl (9μg) and onco-
Dbl (0.1 μg) in the pEBG vector were co-transfected with Myc-tagged CHIP (2 μg) using 
10cm plates of COS7 cells with Fugene6 (Roche). The cells were lysed forty-eight hours 
later. The expression of the lysates was visualized by western blotting using anti-GST 
antibodies and anti-Myc antibodies (B). GST-tagged proteins were precipitated from the 
lysates using glutathione-agarose precipitation (5 hours, 4°C) and visualized by western 
blotting with anti-GST and anti-myc antibodies (A).   
 
Figure 2. Proto-Dbl but not onco-Dbl is ubiquitinated in vivo. (Data courtesy of Dr. 
Elena Kamynina). Proto-Dbl and onco-Dbl (in pEBG vector) were co-transfected with 
Myc-tagged ubiquitin (in pCW7 vector). In order to prevent proteasomal degradation, the 
cells were treated with MG132 (25μM for six hours) forty hours post-transfection. The 
cells were lysed and the lysates were visualized by running a western blot and incubating 
with anti-Dbl and anti-Myc antibodies. GST-tagged proteins were precipitated from the 
lysates using glutathione-agarose precipitation and ubiquitination was evaluated by 
western blotting with anti-Myc antibodies.  
 
Figure 3. Expression of proto-Dbl increases with decreasing levels of endogenous 
CHIP. NIH3T3 cells were transfected with siRNA specific for endogenous CHIP 
(pSUPER vector) using LipfectAmine2000 (Invitrogen). They were lysed and the 
expression of Dbl and CHIP were visualized using anti-Dbl and anti-CHIP antibodies. As 
a control, the membrane was stripped and incubated with anti-actin antibodies. 
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Figure 4. Proto-Dbl levels in vivo decrease with increasing levels of wild-type CHIP, 
remain constant with increasing levels of CHIP(ΔUbox) and increase with 
increasing levels of CHIP(ΔTPR) while onco-Dbl levels remain unaffected. (A) COS7 
cells were transfected with s-tagged proto-Dbl (in pCMV6 vector) and either Xpress-
tagged wild-type CHIP, CHIP(ΔTPR) or CHIP(ΔUbox) (in pcDNA4.1 HisMax vector). 
Each CHIP construct was transfected in increasing amounts (0, 0.2 and 1.0 μg cDNA per 
32mm plate). The cells were lysed forty-eight hours post-transfection and the expression 
of proto-Dbl and CHIP were visualized by western blotting. Proto-Dbl levels were 
quantified by measuring the intensity of the bands. These values were averaged from 3-5 
independent experiments and were used to produce the graph shown. (B) Onco-Dbl 
levels were not affected by varying levels of CHIP or by using mutants of CHIP 
(experimental details described in panel A).  
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